OA05.02 Epacadostat Plus Pembrolizumab in Patients with Non-Small Cell Lung Cancer: Phase 1/2 Results from ECHO-202/KEYNOTE-037

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
• 作者

  L. Villaruz; B. Schneider; T. Bauer; A. Spira; G. DAmato; J. Wasser; A. Balmanoukian; P. Lara; A. Olszanski; T. Gajewski; S. Patel; A. Tarhini; J. Bauml; E. Schmidt; J. Bowman; J. Daniel; S. Owens; T. Mitchell;

  展开▼
• 作者单位

  University of Pittsburgh;

  University of Michigan;

  Sarah Cannon Cancer Research Institute/Tennessee Oncology Pllc;

  Virginia Cancer Specialists Fairfax;

  Northside Hospital Cancer Institute;

  University of Connecticut Health Center;

  The Angeles Clinic and Research Institute;

  UC Davis Comprehensive Cancer Center;

  Fox Chase Cancer Center Temple Health;

  The University of Chicago;

  University of California San Diego Health;

  University of Pittsburgh;

  Abramson Cancer Center of the University of Pennsylvania;

  Merck and Co. Inc;

  Incyte Corporation;

  Incyte Corporation;

  Incyte Corporation;

  Abramson Cancer Center of the University of Pennsylvania;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词